Acute Anemia After Splenectomy: Evidence‑Based Evaluation and Management

Immediate Hemodynamic Assessment

A systolic blood pressure < 90 mm Hg or a heart rate > 110 bpm defines major hemorrhage and mandates urgent intervention. 1

Baseline complete blood count with differential is essential; post‑splenectomy thrombocytosis is common, with platelet counts typically doubling. 2, 3
Iron studies: ferritin > 30 µg/L excludes absolute iron deficiency, while ferritin > 100 µg/L confirms adequate iron stores. 4
A low reticulocyte count despite anemia indicates inadequate marrow erythropoiesis. 5

Use a restrictive transfusion threshold of hemoglobin 70 g/L for hemodynamically stable patients without cardiovascular disease; increase the threshold to 80 g/L for patients with ischemic heart disease or acute coronary syndrome. This reduces transfusion‑related complications without increasing mortality. 1
Implement a single‑unit red‑cell transfusion policy with reassessment after each unit. 5, 1
In active hemorrhage, maintain hemoglobin > 70 g/L while pursuing definitive bleed control. 1

Activate a massive transfusion protocol for bleeding > 150 mL/min or loss of > 50 % blood volume within 3 hours; deliver O‑negative or group‑specific red cells within 15–20 minutes. 1
Consider surgical re‑exploration if bleeding persists despite resuscitation, especially within the first 24–48 hours post‑operatively. 6

All post‑splenectomy patients require thrombotic risk assessment and prophylaxis; monitor for thrombocytosis (platelet count often doubles). 2, 3, 7

Treat iron deficiency with oral iron when ferritin < 30 µg/L; use intravenous iron if oral therapy is ineffective or if ongoing blood loss is suspected. 4
Replace vitamin B12 and folate deficiencies with appropriate supplementation. 4
A therapeutic trial of oral iron that results in hemoglobin improvement confirms absolute iron deficiency. 4

Consider erythropoietin for persistent anemia after correction of nutritional deficiencies, particularly in trauma patients or those with chronic inflammatory conditions; avoid routine iron supplementation unless combined with ESA therapy. Monitor hemoglobin response and adjust dosing accordingly. 5

Asymptomatic patients with platelet counts > 30 × 10⁹/L require no further treatment. 8, 7, 9, 10
For bleeding or platelet counts < 30 × 10⁹/L, initiate thrombopoietin‑receptor agonists as first‑line therapy. 8, 7, 9, 10
Rituximab may be employed for refractory cases after splenectomy failure. 8, 7, 9, 10

Administer vaccinations against encapsulated organisms—pneumococcal (both conjugate and polysaccharide), meningococcal C conjugate, and Haemophilus influenzae type b—within two weeks of splenectomy. 2, 3
Provide a home supply of antibiotics (penicillin V, erythromycin, or levofloxacin) for any febrile illness. 2, 3
Educate patients to seek urgent medical care for fever > 38 °C and to carry medical‑alert identification indicating asplenic status. 2, 3

Do not delay investigation of acute anemia; assume bleeding or thrombosis until proven otherwise. 1
Do not transfuse liberally; a restrictive hemoglobin threshold of 70 g/L is safe and reduces complications. 5, 1
Do not ignore thrombotic risk; post‑splenectomy thrombocytosis markedly increases the likelihood of thromboembolic events. 2, 3, 7
Do not neglect infection prophylaxis; appropriate vaccination prevents overwhelming post‑splenectomy sepsis. 2, 3
Do not overlook nutritional deficiencies; iron, vitamin B12, and folate deficiencies are common, treatable contributors to persistent anemia. 4

Patients who develop signs suggestive of systemic thrombosis (e.g., unexplained limb swelling, chest pain, shortness of breath, or neurologic changes) should undergo immediate diagnostic work‑up to rule out venous or arterial thrombo‑embolism. [Praxis Medical Insights] 11

All individuals who have undergone splenectomy must receive lifelong prophylaxis against encapsulated organisms, including vaccination against Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae; these measures are mandatory to prevent overwhelming post‑splenectomy infection. [BMJ] 12
The recommended timing for administering these vaccines is within the first two weeks after splenectomy to ensure optimal immune protection. [Praxis Medical Insights] 11

Combined oral contraceptives should be avoided in women with post‑splenectomy thrombocytosis because of the heightened thrombotic risk; progestin‑only formulations are preferred as a safer alternative. [Praxis Medical Insights] 11